ANCHIANO THERAPEUTICS
Anchiano is a biopharmaceutical company that specializes in the development of Targeted Cancer Therapies for the treatment of numerous types of cancer. The Company's technology offers a safe and long-term treatment of cancer, with no adverse effects. BioCancell was co-founded in 2004 by Professor Avraham Hochberg, Professor of Molecular Biology at the Hebrew University of Jerusalem, based on technology developed by him over the past 25 years. The drug candidates developed by the Company are targ... eted and their goal is to selectively destroy the cancer cells without affecting healthy cells (‘Targeted Cancer Therapy'). The approach is based on the identification of target genes, such as H19, that are expressed only in cancerous tumors, and not in healthy cells, and on the use of those genes' regulatory sequences for the activation of a toxin inside the cancerous cells only, thus destroying them without harming healthy cells. BioCancell's leading drug candidate, BC-819, has completed a Phase IIb clinical trial for the treatment of bladder cancer, as well as additional clinical trials for other cancer indications. BioCancell’s Phase I clinical trial for BC-821, scheduled to commence in 2015, is a continuation of the success of pre-clinical studies that have examined the use of BC-821 as a treatment for several cancer indications
ANCHIANO THERAPEUTICS
Industry:
Biotechnology Health Care Medical Device
Founded:
2004-01-01
Address:
Jerusalem, Yerushalayim, Israel
Country:
Israel
Website Url:
http://www.anchiano.com
Total Employee:
11+
Status:
Active
Contact:
857-259-4622
Email Addresses:
[email protected]
Total Funding:
29 M USD
Technology used in webpage:
SPF Amazon Amazon Ohio Region NameBright
Similar Organizations
Clinnovate Health
Clinnovate Health is a clinical research organisation focused on integrating research and clinical expertise with health innovation.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Current Employees Featured
Founder
Stock Details
Investors List
Shavit Capital
Shavit Capital investment in Post-IPO Equity - Anchiano Therapeutics
Clal Biotechnology Industries
Clal Biotechnology Industries investment in Post-IPO Equity - Anchiano Therapeutics
Official Site Inspections
http://www.anchiano.com Semrush global rank: 2.61 M Semrush visits lastest month: 2.34 K
- Host name: 104.21.21.80
- IP address: 104.21.21.80
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
